Epitope and HLA-type independent monitoring of antigen-specific T-cells after treatment with dendritic cells presenting full-length tumor antigens

Journal of Immunological Methods

Volumn 377, Issue 1-2, 2012, Pages 23-36

  Van Nuffel, An M T ^a   Tuyaerts, Sandra ^a   Benteyn, Daphné ^a   Wilgenhof, Sofie ^a,b   Corthals, Jurgen ^a   Heirman, Carlo ^a   Neyns, Bart ^b   Thielemans, Kris ^a,b   Bonehill, Aude ^a  

^a FACULTY OF MEDICINE AND PHARMACY   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

CD137; DTH; Full length TAA; Immune monitoring; T cell responses

Indexed keywords

CD137 ANTIGEN; EPITOPE; GAMMA INTERFERON; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL EVALUATION; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; IN VITRO STUDY; LEUKAPHERESIS; LYMPHOCYTIC INFILTRATION; MELANOMA; PRIORITY JOURNAL; PUNCH BIOPSY; RECEPTOR UPREGULATION; SKIN BIOPSY; T LYMPHOCYTE;

ANTIGENS, CD137; ANTIGENS, NEOPLASM; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOPHENOTYPING; IMMUNOTHERAPY, ADOPTIVE; INTERFERON-GAMMA; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MELANOMA; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857783255     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2011.12.010     Document Type: Article

References (48)

1. Aarntzen E.H., Figdor C.G., Adema G.J., Punt C.J., de Vries I.J. Dendritic cell vaccination and immune monitoring. Cancer Immunol. Immunother. 2008, 57:1559-1568.
2. Allard S.D., Pletinckx K., Breckpot K., Heirman C., Bonehill A., Michiels A., van Baalen C.A., Gruters R.A., Osterhaus A.D., Lacor P., Thielemans K., Aerts J.L. Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef. Vaccine 2008, 26:3735-3741.
3. Annunziato F., Romagnani S. Heterogeneity of human effector CD4+ T cells. Arthritis Res. Ther. 2009, 11:257.
4. Beier K.C., Hutloff A., Dittrich A.M., Heuck C., Rauch A., Buchner K., Ludewig B., Ochs H.D., Mages H.W., Kroczek R.A. Induction, binding specificity and function of human ICOS. Eur. J. Immunol. 2000, 30:3707-3717.
5. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., Koup R.A. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 2003, 281:65-78.
6. Bonehill A., Heirman C., Tuyaerts S., Michiels A., Breckpot K., Brasseur F., Zhang Y., Van Der Bruggen P., Thielemans K. Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules. J. Immunol. 2004, 172:6649-6657.
7. Bonehill A., Van Nuffel A.M., Corthals J., Tuyaerts S., Heirman C., Francois V., Colau D., van der Bruggen P., Neyns B., Thielemans K. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients. Clin. Cancer Res. 2009, 15:3366-3375.
8. Bonvalet M., Wambre E., Moussu H., Horiot S., Kwok W.W., Louise A., Ebo D., Hoarau C., Van Overtvelt L., Baron-Bodo V., Moingeon P. Comparison between major histocompatibility complex class II tetramer staining and surface expression of activation markers for the detection of allergen-specific CD4 T cells. Clin. Exp. Allergy 2011, 41:821-829.
9. Casalegno-Garduno R., Schmitt A., Yao J., Wang X., Xu X., Freund M., Schmitt M. Multimer technologies for detection and adoptive transfer of antigen-specific T cells. Cancer Immunol. Immunother. 2010, 59:195-202.
10. Chattopadhyay P.K., Price D.A., Harper T.F., Betts M.R., Yu J., Gostick E., Perfetto S.P., Goepfert P., Koup R.A., De Rosa S.C., Bruchez M.P., Roederer M. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat. Med. 2006, 12:972-977.
11. Chattopadhyay P.K., Yu J., Roederer M. Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expression. Nat. Protoc. 2006, 1:1-6.
12. Chattopadhyay P.K., Hogerkorp C.M., Roederer M. A chromatic explosion: the development and future of multiparameter flow cytometry. Immunology 2008, 125:441-449.
13. de Vries I.J., Bernsen M.R., Lesterhuis W.J., Scharenborg N.M., Strijk S.P., Gerritsen M.J., Ruiter D.J., Figdor C.G., Punt C.J., Adema G.J. Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome. J. Clin. Oncol. 2005, 23:5779-5787.
14. Djoba Siawaya J.F., Roberts T., Babb C., Black G., Golakai H.J., Stanley K., Bapela N.B., Hoal E., Parida S., van Helden P., Walzl G. An evaluation of commercial fluorescent bead-based luminex cytokine assays. PLoS One 2008, 3:e2535.
15. Frentsch M., Arbach O., Kirchhoff D., Moewes B., Worm M., Rothe M., Scheffold A., Thiel A. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat. Med. 2005, 11:1118-1124.
16. Gramaglia I., Weinberg A.D., Lemon M., Croft M. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J. Immunol. 1998, 161:6510-6517.
17. Haanen J.B., Baars A., Gomez R., Weder P., Smits M., de Gruijl T.D., von Blomberg B.M., Bloemena E., Scheper R.J., van Ham S.M., Pinedo H.M., van den Eertwegh A.J. Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients. Cancer Immunol. Immunother. 2006, 55:451-458.
18. Hadrup S.R., Bakker A.H., Shu C.J., Andersen R.S., van Veluw J., Hombrink P., Castermans E., Thor Straten P., Blank C., Haanen J.B., Heemskerk M.H., Schumacher T.N. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat. Methods 2009, 6:520-526.
19. Heiser A., Coleman D., Dannull J., Yancey D., Maurice M.A., Lallas C.D., Dahm P., Niedzwiecki D., Gilboa E., Vieweg J. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J. Clin. Invest. 2002, 109:409-417.
20. Hernandez-Fuentes M.P., Warrens A.N., Lechler R.I. Immunologic monitoring. Immunol. Rev. 2003, 196:247-264.
21. Housseau F., Lindsey K.R., Oberholtzer S.D., Gonzales M.I., Boutin P., Moorthy A.K., Shankara S., Roberts B.L., Topalian S.L. Quantitative real-time RT-PCR as a method for monitoring T lymphocyte reactivity to full-length tyrosinase protein in vaccinated melanoma patients. J. Immunol. Methods 2002, 266:87-103.
22. Issekutz T., Chu E., Geha R.S. Antigen presentation by human B cells: T cell proliferation induced by Epstein Barr virus B lymphoblastoid cells. J. Immunol. 1982, 129:1446-1450.
23. Kantoff P.W., Higano C.S., Shore N.D., Berger E.R., Small E.J., Penson D.F., Redfern C.H., Ferrari A.C., Dreicer R., Sims R.B., Xu Y., Frohlich M.W., Schellhammer P.F. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N. Engl. J. Med. 2010, 363:411-422.
24. Keilholz U., Martus P., Scheibenbogen C. Immune monitoring of T-cell responses in cancer vaccine development. Clin. Cancer Res. 2006, 12:2346-2352.
25. Knights A.J., Nuber N., Thomson C.W., de la Rosa O., Jager E., Tiercy J.M., van den Broek M., Pascolo S., Knuth A., Zippelius A. Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients. Cancer Immunol. Immunother. 2009, 58:325-338.
26. Kreiter S., Selmi A., Diken M., Sebastian M., Osterloh P., Schild H., Huber C., Tureci O., Sahin U. Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals. J. Immunol. 2008, 180:309-318.
27. Kyte J.A., Trachsel S., Risberg B., thor Straten P., Lislerud K., Gaudernack G. Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination. Cancer Immunol. Immunother. 2009, 58:1609-1626.
28. Ladanyi A., Kiss J., Somlai B., Gilde K., Fejos Z., Mohos A., Gaudi I., Timar J. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunol. Immunother. 2007, 56:1459-1469.
29. Morse M.A., Nair S.K., Mosca P.J., Hobeika A.C., Clay T.M., Deng Y., Boczkowski D., Proia A., Neidzwiecki D., Clavien P.A., Hurwitz H.I., Schlom J., Gilboa E., Lyerly H.K. Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA. Cancer Invest. 2003, 21:341-349.
30. Newell E.W., Klein L.O., Yu W., Davis M.M. Simultaneous detection of many T-cell specificities using combinatorial tetramer staining. Nat. Methods 2009, 6:497-499.
31. Peng B., Robert-Guroff M. Deletion of N-terminal myristoylation site of HIV Nef abrogates both MHC-1 and CD4 down-regulation. Immunol. Lett. 2001, 78:195-200.
32. Schultz-Thater E., Frey D.M., Margelli D., Raafat N., Feder-Mengus C., Spagnoli G.C., Zajac P. Whole blood assessment of antigen specific cellular immune response by real time quantitative PCR: a versatile monitoring and discovery tool. J. Transl. Med. 2008, 6:58.
33. Schwartzentruber D.J., Lawson D.H., Richards J.M., Conry R.M., Miller D.M., Treisman J., Gailani F., Riley L., Conlon K., Pockaj B., Kendra K.L., White R.L., Gonzalez R., Kuzel T.M., Curti B., Leming P.D., Whitman E.D., Balkissoon J., Reintgen D.S., Kaufman H., Marincola F.M., Merino M.J., Rosenberg S.A., Choyke P., Vena D., Hwu P. gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N. Engl. J. Med. 2011, 364:2119-2127.
34. Selleri S., Deola S., Pos Z., Jin P., Worschech A., Slezak S.L., Rumio C., Panelli M.C., Maric D., Stroncek D.F., Wang E., Marincola F.M. GM-CSF/IL-3/IL-5 receptor common beta chain (CD131) expression as a biomarker of antigen-stimulated CD8+ T cells. J. Transl. Med. 2008, 6:17.
35. Su Z., Dannull J., Yang B.K., Dahm P., Coleman D., Yancey D., Sichi S., Niedzwiecki D., Boczkowski D., Gilboa E., Vieweg J. Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer. J. Immunol. 2005, 174:3798-3807.
36. Tjin E.P., Konijnenberg D., Krebbers G., Mallo H., Drijfhout J.W., Franken K.L., van der Horst C.M., Bos J.D., Nieweg O.E., Kroon B.B., Haanen J.B., Melief C.J., Vyth-Dreese F.A., Luiten R.M. T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy. Clin. Cancer Res. 2011, 17:5736-5747.
37. Topalian S.L., Rivoltini L., Mancini M., Ng J., Hartzman R.J., Rosenberg S.A. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells. Int. J. Cancer 1994, 58:69-79.
38. Van Camp K., Cools N., Stein B., Van de Velde A., Goossens H., Berneman Z.N., Van Tendeloo V. Efficient mRNA electroporation of peripheral blood mononuclear cells to detect memory T cell responses for immunomonitoring purposes. J. Immunol. Methods 2010, 354:1-10.
39. van der Bruggen, P., Stroobant, V., Vigneron, N., Van den Eynde B. Accessed 4 October, 2011. http://www.cancerimmunity.org/peptidedatabase/Tcellepitopes.htm.
40. Van Nuffel, A.M.T, Benteyn, D., Wilgenhof, S., Pierret, L., Corthals, J., Heirman, C., van der Bruggen, P., Coulie, P., Neyns, B., Thielemans, K., Bonehill, A., in press. Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients. Mol. Ther.
41. Van Tendeloo V.F., Van de Velde A., Van Driessche A., Cools N., Anguille S., Ladell K., Gostick E., Vermeulen K., Pieters K., Nijs G., Stein B., Smits E.L., Schroyens W.A., Gadisseur A.P., Vrelust I., Jorens P.G., Goossens H., de Vries I.J., Price D.A., Oji Y., Oka Y., Sugiyama H., Berneman Z.N. Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:13824-13829.
42. Watanabe K., Suzuki S., Kamei M., Toji S., Kawase T., Takahashi T., Kuzushima K., Akatsuka Y. CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy. Int. J. Hematol. 2008, 88:311-320.
43. Wehler T.C., Karg M., Distler E., Konur A., Nonn M., Meyer R.G., Huber C., Hartwig U.F., Herr W. Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression. J. Immunol. Methods 2008, 339:23-37.
44. Wilgenhof S., Van Nuffel A.M., Corthals J., Heirman C., Tuyaerts S., Benteyn D., De Coninck A., Van Riet I., Verfaillie G., Vandeloo J., Bonehill A., Thielemans K., Neyns B. Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma. J. Immunother. 2011, 34:448-456.
45. Wolfl M., Kuball J., Ho W.Y., Nguyen H., Manley T.J., Bleakley M., Greenberg P.D. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood 2007, 110:201-210.
46. Yang S., Kittlesen D., Slingluff C.L., Vervaert C.E., Seigler H.F., Darrow T.L. Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3. J. Immunol. 2000, 164:4204-4211.
47. Zaunders J.J., Munier M.L., Seddiki N., Pett S., Ip S., Bailey M., Xu Y., Brown K., Dyer W.B., Kim M., de Rose R., Kent S.J., Jiang L., Breit S.N., Emery S., Cunningham A.L., Cooper D.A., Kelleher A.D. High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40). J. Immunol. 2009, 183:2827-2836.
48. Zhang X., Voskens C.J., Sallin M., Maniar A., Montes C.L., Zhang Y., Lin W., Li G., Burch E., Tan M., Hertzano R., Chapoval A.I., Tamada K., Gastman B.R., Schulze D.H., Strome S.E. CD137 promotes proliferation and survival of human B cells. J Immunol 2010, 184:787-795.